CX3CR1 and cancer: The CX3CL1-CX3CR1 signaling axis, formed by a ligand–receptor interaction between transmembrane CX3CL1 and its cognate receptor, modulates malignant phenotypes encompassing proliferation, migration, invasion, and apoptosis resistance in cancer, suggesting its therapeutic relevance (36).